Immunoglobulin therapy for IgA nephropathy: when is cost saving enough?
F A
FA
Sonnenberg
D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D005922:Glomerulonephritis, IGA / Q000191:economics / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive / Q000191:economics*; D006435:Renal Dialysis / Q000191:economics